Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 6/20 | 0.55 |
| ▸ | APLNR | P35414 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.55 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31040681 | 0.98 | EPHA2 (0.56) | EPHA2APLNROPRM1OPRK1CTSL | |
| SCHEMBL30526201 | 0.97 | OPRM1 (0.57) | EPHA2APLNROPRM1OPRK1CTSL | |
| SCHEMBL30973967 | 0.94 | CTSL (0.57) | EPHA2APLNROPRM1OPRK1CTSL | |
| SCHEMBL30753629 | 0.91 | APLNR (0.62) | APLNROPRM1OPRK1 | |
| SCHEMBL30974445 | 0.90 | CALCRL (0.55) | EPHA2APLNRCTSLCTSSCTSK | |
| SCHEMBL29697039 | 0.89 | EPHA2 (0.58) | EPHA2APLNRCXCR4 | |
| SCHEMBL31437675 | 0.89 | REN (0.53) | — | |
| SCHEMBL31384594 | 0.88 | MC4R (0.54) | APLNROPRM1OPRK1 | |
| SCHEMBL31384597 | 0.88 | MC4R (0.54) | APLNROPRM1OPRK1 | |
| SCHEMBL30974054 | 0.87 | CALCRL (0.56) | EPHA2APLNRCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110144374-B | Egg white peptide capable of promoting skin wound healing and preparation method thereof | 吉林大学 | 2022-04-29 | — | — | CN | disclosed |